Stay updated on Atezolizumab in Esophageal Cancer: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.

Latest updates to the Atezolizumab in Esophageal Cancer: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page; this is a minor metadata change that does not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1; no changes to study content, eligibility criteria, or results were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedTaiwan trial site entries were renamed from 'Tainan City, Taiwan, 00704' and 'Tainan City, Taiwan, 710' to 'Tainan, Taiwan, 00704' and 'Tainan, Taiwan, 710'.SummaryDifference0.2%

- Check46 days agoChange DetectedNo substantive additions or deletions were observed; the Study Details page content and layout appear unchanged (title, study details, eligibility criteria, and locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange Detected- The page has updated dates and a new note that the study now includes 165 locations (previously 166). - The page now shows an estimated last update date (Last Update Posted (Estimated)) for 2025-10, and an entry for 2025-10-09. - Several specific location-related entries were removed, including reference to Saint Petersburg/Sankt-Peterburg, Russia (institution name) and an entry titled Sankt-Peterburg Locations, as well as the prior date 2025-07-14 and a generic 2025-07 timestamp. - The explicit note that the study had 166 locations was deleted and replaced with 165 locations, indicating a change in scope or count. - Overall, the changes indicate a reduction in listed locations and an updated timestamp/summary for the current state, rather than a major alteration of core content.SummaryDifference1.0%

- Check76 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab in Esophageal Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.